Downregulation of Mirlet7 miRNA family promotes Tc17 differentiation and emphysema via de-repression of RORγt
eLife assessment
This important study indicates a significant role for individual let-7 miRNA clusters in regulating generation of Tc17 CD8 cells and emphysema severity in a mouse model. The authors provide convincing evidence for let-7-mediated repression of the transcription factor RORgt and consequent modulation of IL-17-producing CD8 T cells, with correlated data from human emphysema material, though some of the effective let-7 clusters remain to be tested for the ability to modulate disease. The findings, which substantially advance the understanding of roles that let-7 miRNA clusters play in modulating both T cell responses and emphysematous lung disease, will be of interest to T cell and lung disease researchers.
https://doi.org/10.7554/eLife.92879.3.sa0Important: Findings that have theoretical or practical implications beyond a single subfield
- Landmark
- Fundamental
- Important
- Valuable
- Useful
Convincing: Appropriate and validated methodology in line with current state-of-the-art
- Exceptional
- Compelling
- Convincing
- Solid
- Incomplete
- Inadequate
During the peer-review process the editor and reviewers write an eLife Assessment that summarises the significance of the findings reported in the article (on a scale ranging from landmark to useful) and the strength of the evidence (on a scale ranging from exceptional to inadequate). Learn more about eLife Assessments
Abstract
Environmental air irritants including nanosized carbon black (nCB) can drive systemic inflammation, promoting chronic obstructive pulmonary disease (COPD) and emphysema development. The let-7 microRNA (Mirlet7 miRNA) family is associated with IL-17-driven T cell inflammation, a canonical signature of lung inflammation. Recent evidence suggests the Mirlet7 family is downregulated in patients with COPD, however, whether this repression conveys a functional consequence on emphysema pathology has not been elucidated. Here, we show that overall expression of the Mirlet7 clusters, Mirlet7b/Mirlet7c2 and Mirlet7a1/Mirlet7f1/Mirlet7d, are reduced in the lungs and T cells of smokers with emphysema as well as in mice with cigarette smoke (CS)- or nCB-elicited emphysema. We demonstrate that loss of the Mirlet7b/Mirlet7c2 cluster in T cells predisposed mice to exaggerated CS- or nCB-elicited emphysema. Furthermore, ablation of the Mirlet7b/Mirlet7c2 cluster enhanced CD8+IL17a+ T cells (Tc17) formation in emphysema development in mice. Additionally, transgenic mice overexpressing Mirlet7g in T cells are resistant to Tc17 and CD4+IL17a+ T cells (Th17) development when exposed to nCB. Mechanistically, our findings reveal the master regulator of Tc17/Th17 differentiation, RAR-related orphan receptor gamma t (RORγt), as a direct target of Mirlet7 in T cells. Overall, our findings shed light on the Mirlet7/RORγt axis with Mirlet7 acting as a molecular brake in the generation of Tc17 cells and suggest a novel therapeutic approach for tempering the augmented IL-17-mediated response in emphysema.
Introduction
Chronic obstructive pulmonary disease (COPD) ranks as the third leading cause of mortality and is projected to account for over a billion deaths by the end of the 21st century (GBD Chronic Respiratory Disease Collaborators, 2020; Institute for Health Metrics and Evaluation, 2019; Laniado-Laborín, 2009). Currently, there are no treatment options to reverse emphysema, the most clinically significant variant of COPD, which often is progressive despite smoking cessation (Bhavani et al., 2015; Anthonisen et al., 2002).
Inhalation of fine particulate matter smaller than 2.5 microns (PM2.5) found in outdoor and indoor air pollution as well as tobacco smoke are risk factors for COPD development (Adeloye et al., 2022; Eisner et al., 2010; Hu et al., 2010). We have previously shown that nanosized carbon black (nCB), a noxious chemical constituent of PM2.5 found in the lungs of smokers, activates macrophages and dendritic cells orchestrating a pathogenic T cell-dependent inflammatory response and emphysema in mice (Lu et al., 2015; You et al., 2015; Shan et al., 2009; Chang et al., 2022).
Research over the last decade has pointed to the importance of dysfunctional inflammatory T cells in human COPD lung tissue and animal models of emphysema (Grumelli et al., 2004; Xu et al., 2012; Williams et al., 2021). Aberrant T cells are implicated in impaired host defense, exaggerated inflammation, and loss of self-tolerance in COPD (Williams et al., 2021; Chen et al., 2023; Hogg et al., 2004; Maeno et al., 2007; Xu et al., 2012). In this regard, we and others have demonstrated the role and pathogenicity of activated IFN-γ and IL-17-secreting subsets of CD4+ and CD8+ T lymphocytes including Th1, Th17, and Tc1 cells in clinical isolates and in mice with COPD (Lu et al., 2015; You et al., 2015; Shan et al., 2009; Lee et al., 2007; Kheradmand et al., 2023). The IL-17-secreting Th17 cells are particularly important as they promote the destruction of lung epithelium and recruitment of macrophages and neutrophils which then release proteolytic enzymes such as matrix metalloproteinases involved in the degradation of the lung structural matrix (Barnes, 2016; Hoenderdos and Condliffe, 2013). We previously demonstrated that intranasal inhalation of nCB in mice is sufficient to induce emphysema by stimulating lung T cell activation by dendritic cells and macrophages. Moreover, we found that genetic ablation of IL-17A can attenuate nCB- or cigarette smoke (CS)-induced alveolar destruction and airway inflammation (Shan et al., 2012; You et al., 2015). More recently, IL-17A- and IL-17F-secreting CD8+ T cell (Tc17) subpopulation has been shown to play a critical role in the pathogenesis of several autoimmune and inflammatory disorders (Globig et al., 2022; Huber et al., 2013; Srenathan et al., 2016).
Both Th17 and Tc17 require the fate-deterministic transcription factor RAR-related orphan receptor gamma t (RORγt, encoded by Rorc) for differentiation and production of IL-17A (Ivanov et al., 2007). RORγt is the best-studied positive transcriptional regulator of IL-17A and IL-17F (Ivanov et al., 2006). In accordance with the importance of IL-17A transcription, RORγt expression has also been reported to be elevated in COPD patients and in mouse models of COPD (Chu et al., 2011; Li et al., 2015). However, the upstream pathophysiologic mechanisms that contribute to the induction of RORγt and differentiation of Tc17 cells in COPD have not been well elucidated.
We previously reported that Mir22 inhibits HDAC4, promoting antigen-presenting cell (APC) activation in the lungs and inducing Th17-mediated emphysema in response to CS or nCB in mice (Lu et al., 2015). Additional microRNAs (miRNAs) that control APC and/or T cell-driven IL-17A+ inflammation have been identified by others including the Mirlet7 family (Yang, 2012; Angelou et al., 2019). miRNA expression-based studies have shown frequent downregulation of members of the Mirlet7 family, including Mirlet7a, Mirlet7b, Mirlet7c, Mirlet7d, Mirlet7e, and Mirlet7f in human emphysematous lung tissue and in murine models of emphysema, but the mechanism(s) of action remain ill-defined (Christenson et al., 2013; Pottelberge et al., 2011; Conickx et al., 2017; Izzotti et al., 2009). Mirlet7 genes are encoded across eight loci either as single genes or as polycistronic clusters which have confounded their analysis in vivo (Rodriguez et al., 2004). Previous studies used Lin28b transgenic overexpression in T cells to block the maturation and processing of the Mirlet7 family. They showed an inhibitory role of Mirlet7 family in Th17-driven response in the murine model of experimental autoimmune encephalomyelitis attributed in part to regulation of IL-1 receptor 1 and IL-23 receptor (Angelou et al., 2019).
Here, we found that MIRLET7, notably the MIRLET7A3/MIRLET7B and MIRLET7A1/MIRLET7F1/MIRLET7D clusters, are suppressed in the T cells isolated from lungs of emphysema patients. Consistently, the analogous murine Mirlet7b/Mirlet7c2 and Mirlet7a1/Mirlet7f1/Mirlet7d clusters, respectively, were similarly downregulated in pre-clinical emphysema models. We engineered mouse models with the specific loss-of-function (LOF) mutations of the Mirlet7b/Mirlet7c2 and Mirlet7a1/Mirlet7f1/Mirlet7d clusters, respectively, in T cells as well as an inducible Mirlet7g gain-of-function (GOF) model to determine the T cell-intrinsic role of Mirlet7 miRNA in emphysema pathogenesis. Deletion of Mirlet7 miRNA in T cells worsened alveolar damage elicited by inhalation of CS or nCB, and increased infiltration of immune cells in the airways, including IL-17-producing CD8+ T (Tc17) cells. Mechanistically, we found that Mirlet7 controls type 17 differentiation by directly targeting the lineage-determining transcription factor, RORγt. In support of this conclusion, Mirlet7 GOF mice were resistant to nCB-mediated induction of RORγt and Tc17 responses. Thus, we show a previously unappreciated role for Mirlet7 as a repressor of RORγt and a molecular brake to the IL-17-mediated T cell inflammation in emphysema.
Results
The Mirlet7b/Mirlet7c2 and Mirlet7a1/Mirlet7f1/Mirlet7d clusters are downregulated in lungs and T cells in COPD
To explore the involvement of Mirlet7 in emphysema, we scrutinized the genomic locations and transcriptional annotation of Mirlet7 members frequently downregulated in lung T cells isolated from smoker’s lungs as well as mouse models of emphysema. This combined approach showed close linkage and high conservation of two Mirlet7 clusters encoded from long intergenic non-coding RNA (linc)-like precursors in humans and mice (Figure 1A). To shed light on whether these Mirlet7 clusters are downregulated in patients with COPD, we analyzed a published (GSE57148) lung RNA-seq dataset obtained from COPD (n = 98) and control (n = 91) subjects (Kim et al., 2015). Our analysis identified significant downregulation of the Mirlet7ahg and Mirlet7bhg gene cluster transcripts in COPD compared to control subjects (Figure 1B). We carried out quantitative PCR (qPCR) detection of MIRLET7A, which is encoded by both clusters, in lung tissue samples of smokers with emphysema and non-emphysema controls, detecting significant downregulation of MIRLET7A in emphysema samples relative to controls (Figure 1C). Because Mirlet7 has been shown to participate in IL-17+ T cell responses (Angelou et al., 2019; Guan et al., 2013; Newcomb et al., 2015), we next sought to determine if the expression pattern of Mirlet7ahg and Mirlet7bhg-derived Mirlet7 members are impaired in purified CD4+ T cells from emphysematous lungs. In support of our original hypothesis, the CD4+ T cell expression of Mirlet7a, Mirlet7b, Mirlet7d, and Mirlet7f were all inversely correlated with more severe emphysema distribution in the lungs as determined by Computed Tomography (CT) scan (Figure 1D).
Next, we elucidated Mirlet7b/Mirlet7c2 and Mirlet7a1/Mirlet7f1/Mirlet7d cluster expression (herein referred to as Mirlet7bc2 and Mirlet7afd, respectively) in murine models of CS- or nCB-induced emphysema, respectively (Figure 1E). Paralleling our observations in human COPD and emphysema, mice with CS- or nCB-induced emphysema exhibited reduced expression levels of pri-Mirlet7b/c2 and pri-Mirlet7a1/f1/d transcripts in the lung and from isolated lung CD4+ and CD8+ T cells (Figure 1F–H). Collectively, our expression results indicate suppression of Mirlet7bc2 and Mirlet7afd in the lung and T cells in human and pre-clinical models of emphysema.
Conditional deletion of the Mirlet7bc2 cluster in T cells enhances nCB- or CS-induced emphysema
To investigate the in vivo requirement of the Mirlet7bc2 within T cells, we generated conditional ready floxed mice (let7bc2f/f). We then crossed let7bc2f/f mice with CD4-Cre mice to generate let7bc2f/f; CD4-Cre LOF mice (let7bc2LOF) (Figure 2A). This approach allowed us to conditionally delete Mirlet7bc2 in all T cells derived from the CD4+CD8+ double-positive (DP) stage (Lee et al., 2001; Shi and Petrie, 2012). We confirmed that let7bc2LOF mice exhibit robust conditional deletion of Mirlet7bc2 in DP thymocytes and peripheral T cells (Figure 2B and data not shown). Our let7bc2LOF adult mice were born at the expected Mendelian frequency and did not show any overt histopathologic or inflammatory changes in lungs histopathology up to 1 year of age in comparison to let7bc2f/f control mice (Figure 2—figure supplement 1A–D). Furthermore, quantification of major immune populations and T cell subsets by flow cytometry in let7bc2LOF were comparable to control mice under baseline conditions and with moderate aging (Figure 2—figure supplement 1C, D).
We next exposed let7bc2LOF and let7bc2f/f control mice to nCB or CS and examined the lungs under the context of experimental emphysema. Histomorphometry measurements of mean linear intercept (MLI) from hematoxylin and eosin (H&E)-stained sections revealed that the enlargement of alveolar spaces sustained from either nCB or CS exposure was exaggerated in let7bc2LOF mice relative to controls (Figure 2C–E). Chronic inflammation in emphysema is characterized by the recruitment of macrophages and neutrophils to the lung tissue and airways (Peleman et al., 1999; Senior and Anthonisen, 1998). Internally consistent with MLI measurements, let7bc2LOF mice treated with nCB showed significantly increased airway infiltration of macrophages and neutrophils in BAL fluid as compared to wild-type control animals (Figure 2F). Concomitant with these findings, expression levels of Mmp9 and Mmp12, which are secreted by macrophages and neutrophils to degrade elastin and mediate alveolar damage, were elevated in airways of let7bc2LOF mice exposed to CS versus controls (Figure 2G). As expected, let7bc2LOF mice treated with nCB exhibit significantly less pri-Mirlet7b/c2 transcript expression in isolated lung T cells relative to wild-type control mice (Figure 2—figure supplement 2A and data not shown). Collectively, our data suggest that the Mirlet7bc2 cluster within T cells protects by dampening airway destruction and inflammation because the absence of this cluster worsens the severity of experimental emphysema in mice.
The Mirlet7b/Mirlet7c2 cluster negatively regulates TC17 inflammation in emphysema
We sought to identify the T cell-intrinsic mechanisms that underlie the exaggerated inflammation observed in emphysematous let7bc2LOF mice. We focused on the IL-17-mediated T cell response because it promotes neutrophil and macrophage recruitment in the lungs (Beringer et al., 2016; Veldhoen, 2017; Shan et al., 2012). Previously, we established the induction of CD4+IL17+ (Th17) cells along with CD4+IFNγ+ (Th1) cells in mice with chronic nCB exposure (You et al., 2015), however whether nCB similarly induces CD8+IL17A+ T cells (Tc17) or cytotoxic T cells (Tc1) had not been studied. The flow cytometric profiling of lung T cells revealed enriched proportions and counts of Tc1/Tc17 as well as Th1/Th17 cells in wild-type mice upon treatment with nCB (Figure 3A, B and Figure 3—figure supplement 1A). These findings suggests that nCB elicits both the type 17 and type 1T cell responses, consistent with CS and elastase pre-clinical models of emphysema (Zhang et al., 2019).
We next interrogated the regulatory role of Mirlet7bc2 in the type 17 and type 1 responses generated from exposure to nCB. Interestingly, let7bc2LOF mice showed increased CD8+IL17A+ Tc17 cells relative to nCB control animals. In contrast, CD8+IFNγ+ and GZMA+ Tc1 populations remained unperturbed with absence of Mirlet7bc2, suggestive of a more refined regulatory role on Tc17 differentiation (Figure 3A, B). There were no significant differences in either Th1 or Th17 cells when comparing nCB-treated let7bc2LOF to wild-type controls, indicating the Mirlet7bc2 was dispensable for their generation (Figure 3C). Regulatory T cells form a dynamic axis with Tc17/Th17 cells and act as a counterbalance to lung inflammation in emphysema (Duan et al., 2016; Jin et al., 2014). Therefore, we examined whether Tc17 cell alterations were driven by Mirlet7bc2 acting on regulatory T cells (Tregs). The let7bc2LOF mice showed no significant difference in the Tregs subset relative to controls in our model (Figure 3D). Together, our data support the notion that deletion of Mirlet7bc2 is insufficient to provoke Tc17 cell generation under homeostatic conditions. However, under the context of chronic inflammation in emphysema, the loss of the Mirlet7bc2 cluster is intrinsic for the potentiation of T cells toward Tc17 differentiation.
The Mirlet7 family directly inhibits RORγt expression governing Tc17 differentiation in emphysema
We utilized the TargetScan predictive algorithm to identify putative Mirlet7 targets that are known to control the IL-17-mediated T cell response (Agarwal et al., 2015). This analysis revealed that the 3′UTR region of Rorc, encoding RORγt, contains an evolutionarily conserved and complementary motif for the Mirlet7 family (Figure 4A). Thus, we examined if Mirlet7bc2 loss in T cells would stimulate and enhance RORγt. Initially, we carried out flow cytometric quantification for RORγt in thymocyte, splenic, and lung T cells of naïve control and let7bc2LOF mice up to 6 months of age. Our interrogation of RORγt mean fluorescent intensity (MFI) by flow cytometry showed induction of RORγt in single-positive CD8+ and CD4+ thymocytes, as well as peripheral splenic CD8+ and CD4+ T cells (Figure 4B). However, RORγt levels appeared unchanged in purified lung CD8+ T cells and CD4+ T cells of naive let7bc2LOF mice, alluding to a compensatory effect in homeostatic lung T cells (Figure 4B). Since we and others have shown that miRNAs are frequently associated with stress-dependent phenotypes, we posited that emphysematous let7bc2LOF T cells are poised toward induction of RORγt and production of IL-17+ subsets after challenge with nCB. Indeed, nCB-emphysematous let7bc2LOF mice exhibited enhanced RORγt protein levels in both CD8+ and CD4+ T cells relative to control mice with emphysema (Figure 4C).
Because we had found that the Mirlet7afd cluster is downregulated in T cells isolated from COPD lungs in human and mice, and that the Mirlet7 family operates with some functional redundancy, we generated mice with conditional deletion of the Mirlet7afd in T cells (let7afdLOF). The let7afdLOF mice aged up to 6 months did not exhibit overt lung histopathology and inflammatory changes (Figure 4—figure supplement 1A–E). Of particular interest, ablation of Mirlet7afd enhanced levels of RORγt in thymic and peripheral T cells of mice (Figure 4D). Overall, this indicates that independent Mirlet7 clusters restrain RORγt expression levels from thymic development to peripheral T cells under homeostatic conditions. Next, we determined whether loss of Mirlet7afd in T cells likewise sensitizes mice toward induction of RORγt in nCB emphysema. Intranasal administration of nCB provoked increased RORγt expression in lung T cells of let7afdLOF mice compared to control mice (Figure 4E), supporting overlapping functionality between the Mirlet7bc2 and Mirlet7afd in repression of RORγt within T cells.
To confirm that the Mirlet7 family negatively regulates Tc17 cell differentiation, at least in part, cell autonomously in CD8+ T cells, we purified naïve CD8+ T cells from let7bc2LOF and control mice spleens and cultured these cells in vitro in the presence of Tc17 polarizing (TGFβ, IL-6, anti-IFNγ, IL-23, and IL-1β) or Tc1 polarizing (IL-2) conditions (Flores-Santibáñez et al., 2018). Our flow cytometric analysis confirmed the enhanced commitment of Mirlet7bc2 deficient CD8+ T cells toward Tc17 cells and IL-17A+ production relative to control CD8+ T cells (Figure 5A, B). Moreover, enhanced Tc17 cell differentiation mirrored the increased IL-17A detected in the supernatant from in vitro polarized cells as quantified by ELISA (Figure 5C). Parallel assessment of Tc1 differentiation did not detect a difference in CD8+IFNγ+ cells (Figure 5A and D). Altogether, these data recapitulated our in vivo findings that the Mirlet7bc2 cluster negatively regulates Tc17 response but is dispensable in Tc1 cells. Finally, to determine whether Tc17 differentiation is likewise controlled by Mirlet7afd, we cultured naive CD8+ splenocytes from let7afdLOF and controls under Tc17 conditions. As we had observed with let7bc2LOF, absence of Mirlet7afd in T cells further enhanced differentiation toward Tc17 cells as quantified by flow cytometry and ELISA (Figure 5F, G).
Next, we focused on Rorc as a potential direct target of Mirlet7, which could mechanistically mediate enhanced Tc17 differentiation in let7bc2LOF mice. Toward this objective, we tested whether let7bc2LOF or let7afdLOF naive CD8+ T cells show elevated RORγt expression under either Tc0 or Tc17 differentiation conditions. In agreement with enhanced Tc17 differentiation, RORγt expression was differentially and significantly upregulated under both Tc0 and Tc17 differentiation conditions in Mirlet7 LOF cells relative to controls (Figure 5E, H). To determine whether Mirlet7 directly represses Rorc mRNA levels we cloned the 3′UTR of Rorc into luciferase constructs. These reporter assays with Mirlet7b expressing cells independently confirmed that Mirlet7b represses Rorc (Figure 5I, left). Furthermore, deletion of the putative Mirlet7-binding sequence (Figure 4A) abrogated repression by Mirlet7b (Figure 5I, right), thus confirming Rorc as a functional target. Overall, these in vitro experiments readily recapitulated an upstream regulatory role of Mirlet7 in Tc17 differentiation, mediated in part, via direct suppression of RORγt.
Enforced expression of Mirlet7g tempers RORγt T cell expression levels in experimental emphysema
To explore a potential protective role of Mirlet7 in experimentally induced emphysema, we generated mice which allowed for selective induction of Mirlet7g in T cells using the published rtTA-iLet7 mice crossed to CD4-Cre (herein referred to as let7GOF; Figure 6A; Angelou et al., 2019; Belteki et al., 2005; Pobezinskaya et al., 2019; Wells et al., 2017; Zhu et al., 2011). The rtTA-iLet7 mouse model has been utilized to promote ~two- to threefold rise in total Mirlet7 activity in T cells (Angelou et al., 2019; Wells et al., 2017; Wells et al., 2023; Angelou et al., 2019). Steady-state let7GOF and control (rtTA-iLet7) mice were examined for compromised RORγt protein levels within thymocytes and peripheral T cells. Providing further evidence of Mirlet7-dependent regulation of Rorc, protein levels of RORγt were suppressed in CD8+ and CD4+ T cells of let7GOF mice relative to controls (Figure 6B). To determine whether enforced expression of Mirlet7g offered protection from experimental emphysema, let7GOF and control mice were treated with nCB and then examined for changes in lung pathology and T cell type 17 responses. The let7GOF mice did not exhibit any signs of lung inflammation or pathologic remodeling at baseline (Figure 6C, D and data not shown). Histopathologic analysis revealed a comparable degree of lung alveolar distension via morphometric measurements of MLI in nCB-treated let7GOF mice versus controls suggesting that enforced Mirlet7g expression is insufficient to protect the lung from emphysema (Figure 6C, D). On the other hand, evaluation of the IL-17+ response and RORγt levels in emphysematous lung T cells demonstrated that, in contrast to control nCB-treated mice, let7GOF mice exhibited dampened lung Tc17 and Th17 cell populations and were resistant to the induction of RORγt after nCB exposure (Figure 6E, F). Taken together, our Mirlet7 LOF and GOF models demonstrate the necessity and sufficiency of Mirlet7 to act as a molecular brake to the type 17T cell response through the direct regulation of RORγt, further our data suggest that nCB- or CS-mediated suppression of this braking mechanism furthers inflammation and exacerbates emphysema severity (Figure 6G).
Discussion
miRNA expression-based studies of COPD patients and mice exposed to CS have reported downregulation of Mirlet7 expression in lung tissues (Conickx et al., 2017; Christenson et al., 2013; Schembri et al., 2009). We and others explored the consequence of loss of Mirlet7 expression/activity with synthetic oligonucleotides, sponges, lentiviral antisense knockdown, or via ectopic delivery of Lin28b (Polikepahad et al., 2010; Viswanathan et al., 2008; Piskounova et al., 2011), but studies pinpointing the role of individual Mirlet7 clusters as potential drivers of lung inflammation and COPD within T cells remained elusive. In the present study, we established that the Mirlet7 family members encoded by the Mirlet7b/Mirlet7c2 and Mirlet7a1/Mirlet7f1/Mirlet7d clusters are downregulated in T cells from lungs of emphysema patients and emphysematous mice that were exposed to CS or nCB. Correspondingly, we demonstrated that in vivo genetic ablation of Mirlet7b/Mirlet7c2 further sensitized mice to lung tissue destruction and emphysema upon treatment with nCB or CS. Mechanistically, our studies suggests that Mirlet7b/Mirlet7c2 cluster prevents the emergence of CD8+ T cell differentiation into Tc17 cells during emphysema in part, by directly silencing of Rorc.
Tc17 cells are vital for defense against viral, fungal, and bacterial infections and they have also been associated with inflammation in various human diseases such as multiple sclerosis, inflammatory bowel disease, and cancer (Huber et al., 2013; Globig et al., 2022; Corgnac et al., 2020). In accordance with the potential pathogenic role of Tc17 cells as drivers of COPD, several studies detected increased cell numbers in airways and tissues of COPD patients as well as lungs of smoke-exposed animal models (Chang et al., 2011; Zhou et al., 2020; Duan et al., 2013). Other researchers also detected increased Tc17 subpopulations in tissues of COPD patients with infectious microbial exacerbations. In our earlier work to define the adaptive T cell immune responses in nCB-induced COPD, we predominantly focused on the pathogenic role of Th17 cells, but did not examine Tc17 cells (You et al., 2015). Here, we expand upon our prior observations, revealing that chronic exposure to nCB and elicitation of emphysema mice orchestrates the emergence and accumulation of Tc17 cells which may act in parallel with Th17 cells to promote tissue damage.
Prior research has shown the importance of both transcriptional and post-transcriptional regulatory control of RORγt expression in T cells (Ciofani et al., 2012; Donate et al., 2013; Medvedev et al., 1997). Altogether, our in vivo studies establish Mirlet7 as a new important link associated with regulation of RORγt and lung Tc17 differentiation in COPD. Our data also showed that in vivo conditional genetic ablation of individual Mirlet7 clusters in T cells stimulates a rise in RORγt protein expression in single-positive thymocytes and peripheral CD8+ and CD4+ T cells while enforced Mirlet7g activity leads to partial repression of RORγt in T cells. Despite these alterations in RORγt expression in our Mirlet7 T cell LOF mice, the mice did not exhibit spontaneous gross phenotypes in thymus, spleens, or lungs at baseline nor did they exhibit changes in Tc17/Th17 subpopulations. This may be due to the subtle and modest expression thresholding of RORγt detected in mice and/or residual Mirlet7 expression in T cells. On the other hand, and in agreement with our Tc17 and experimental emphysema data, we observed enhanced RORγt expression in lungs of Mirlet7 T cell LOF after treatment with nCB. We corroborated the importance of Mirlet7 activity in Tc17 differentiation of ex vivo cultured CD8+ T cells, as well as in the direct post-transcriptional control of RORγt, suggesting that this defect, is in part, direct and cell autonomous. We did not ascertain whether deletion of Mirlet7a1/Mirlet7f1/Mirlet7d cluster is an equally or more effective modulator of experimentally induced emphysema. Nonetheless, we predict that under different cell stress contexts, the functions of Mirlet7 clusters do not fully overlap due to differential thresholding of mRNAs.
Prior studies have elucidated the relative and absolute quantities of individual Mirlet7 family members in murine thymocytes and peripheral T cells which range from ~2% to 30% (Pobezinskaya et al., 2019; Pobezinsky et al., 2015). Moreover, the same group reported that all Mirlet7 miRNAs are coordinately downregulation following antigen stimulation through the T cell receptor (Wells et al., 2017). Another recent study discerned a role for the lncRNA, CCAT1 (colon cancer-associated transcript 1) as a molecular decoy or sponge in human bronchial epithelial cells which drives downregulation of Mirlet7c following CS extract exposure (Lu et al., 2017). Thus, it seems likely that complex synergistic transcriptional and post-transcriptional mechanisms contribute to downregulation of Mirlet7 activity in emphysematous T cells.
It is also important to note that Mirlet7 has been reported to exert potent effects by titrating the levels of multiple gene targets in mechanisms that contribute to Th17 inflammatory response and influence diverse set of processes including T cell activation, proliferation, differentiation, and cell homing (Angelou et al., 2019; Beachy et al., 2012; Bronevetsky et al., 2016; Pobezinskaya et al., 2019; Pobezinsky et al., 2015; Wells et al., 2017). A particular feature of these studies has been the utilization of Lin28b transgenic mice to block maturation and activity of entire Mirlet7 family to promote a LOF function phenotype (Angelou et al., 2019; Piskounova et al., 2011; Pobezinskaya et al., 2019; Wells et al., 2023; Zhu et al., 2011). Furthermore, Lin28b was recently reported to also influence transcriptome-wide ribosome occupancy and global miRNA biogenesis (Tan et al., 2019). Thus, it is likely that Lin28b transgenic overexpression gives rise stronger phenotypes than we observed in our single cluster Mirlet7 T cell LOF mice. Nonetheless, unbiased omics-based methods will be needed to determine if other gene targets beyond RORγt synergistically potentiate the in vivo Tc17 response and emphysema phenotype in context of deletion of Mirlet7b/Mirlet7c2 cluster.
Tc17 cells play a major role in microbial infections, providing a potent anti-viral response (Hamada et al., 2009; Yeh et al., 2010), while viral infection has been an established factor in COPD exacerbations (Hewitt et al., 2016; Wedzicha, 2004). It will be interesting to determine whether loss of Mirlet7 activity in the T cell compartment contributes to COPD disease susceptibility in the context of viral exposure. Our experiments with Mirlet7g GOF were partially successful in limiting the emergence of Tc17 and Th17 in nCB-elicited emphysema. The Mirlet7g GOF mice exhibited a reduction in RORγt expression levels and type 17 responses but were not protected from alveolar remodeling following nCB exposure. A potential limitation of this transgenic model is that it expresses only the Mirlet7g sequence which may render it less potent than the corresponding two mature forms transcribed from the Mirlet7b/Mirlet7c2 cluster. Additional studies will be required to ascertain whether other interventions or alternative mouse models that enhance Mirlet7 activity in T cells are successful in preventing or reversing COPD.
Materials and methods
Mice
Conditional knockout-ready floxed for either the Mirlet7b/Mirlet7c2 and Mirlet7a1/Mirlet7f1/Mirlet7d cluster, respectively, were generated using CRISPR gene editing in an isogenic C57BL/6 genetic background and were sequence verified for rigor. Mice were PCR genotyped from ear samples with primers flanking loxP sites (Supplementary file 1). Mice were crossed to CD4-Cre obtained from JAX (Stock 022071) and genotyped by PCR. The R26-STOP-rtTA; Col1a1-tet0-Mirlet7g (rtTA-iLet7) mice were obtained from JAX (Stocks 023912 and 05670) and also PCR genotyped with established JAX primers (Belteki et al., 2005; Zhu et al., 2011). Control rtTA-iLet7 and Mirlet7g GOF mice were fed ad libitum with 200 mg/kg of doxycycline-containing chow (Bio-Serv S3888) at weaning age (Belteki et al., 2005; Zhu et al., 2011). Syngeneic littermates served as controls for all mouse experiments. All mice were bred in the transgenic animal facility at Baylor College of Medicine. All experimental protocols used in this study were approved by the Institutional Animal Care and Use Committee of Baylor College of Medicine animal protocol (AN-7389) and followed the National Research Council Guide for the Care and Use of Laboratory Animals.
Human emphysema tissue samples and T cell isolation
Request a detailed protocolLung tissues were obtained from a total of 19 non-atopic current or former smokers with significant (>20 pack-years, one pack-year equals to smoking one pack of cigarettes per day each year) history of smoking who were recruited into studies from the chest or surgical clinics at Michael E. DeBakey Houston Veterans Affairs Medical Center hospitals (Supplementary file 2; Shan et al., 2009). Emphysema and non-emphysema control patients were diagnosed from CT scans according to the criteria recommended by the National Institutes of Health–World Health Organization workshop summary (Pauwels et al., 2001). Human single-cell suspensions were prepared from surgically resected lungs as previously described (Yuan et al., 2019; Grumelli et al., 2004). Briefly, fresh lung tissue was minced into 0.1 cm pieces in Petri dishes and treated with 2 mg/ml of collagenase D (Worthington) for 1 hr at 37°C. Digested lung tissue was filtered through a 40-μm cell strainer (BD Falcon) followed by red blood cell lysis using ACK lysis buffer (Sigma-Aldrich) for 3 min to yield a single-cell suspension. CD4+ T cells were selected from resultant suspensions by labeling with bead conjugated anti-CD4 for enrichment by autoMACs (Miltenyi Biotec). Studies were approved by the Institutional Review Board at Baylor College of Medicine and informed consent was obtained from all patients.
Human lung transcriptome data
Request a detailed protocolA publicly available RNA-seq dataset from a Korean cohort GSE57148 was selected for the analysis (Kim et al., 2015). The raw FASTQ files of paired end reads representing the transcriptome of control and cases were retrieved from the GEO database at the National Centre for Biological Information (NCBI) through accession number GSE57148 and analyzed with R package for differential expression.
CS exposure model of pulmonary emphysema
Request a detailed protocolTo promote emphysema, mice were exposed to CS using our custom designed whole-body inhalation system (Morales-Mantilla et al., 2020). In total, mice were exposed to four cigarettes (Marlboro 100’s; Philip Morris USA) per day, 5 days a week, for 4 months as previously described (Shan et al., 2012).
nCB exposure model of pulmonary emphysema
Request a detailed protocolNanosized particulate carbon black was prepared and administered as previously described (You et al., 2015; Lu et al., 2015). Dried nCB nanoparticles were resuspended in sterile PBS to a concentration of 10 mg/ml. Fifty µl of reconstituted nCB (0.5 mg) were intranasally delivered to deeply anesthetized mice on a schedule of three times a week for 4 weeks (total delivered dose of 6 mg). Lung histomorphometry and airway inflammation were assessed 4 weeks after the final nCB challenge. For histomorphometric analysis, mice lungs were fixed with 10% neutral-buffered formalin solution via a tracheal cannula at 25 cm H2O pressure followed by paraffin embedding and tissue sectioning and stained with H&E. MLI measurement of mouse lung morphometry was done as previously described (Shan et al., 2014; Morales-Mantilla et al., 2020). Briefly, this was done in a blinded fashion to mice genotypes from 10 randomly selected fields of lung parenchyma sections. Paralleled lines were placed on serial lung sections and MLI was calculated by multiplying the length and the number of lines per field, divided by the number of intercepts (Morales-Mantilla et al., 2020).
BALF was collected by instilling and withdrawing 0.8 ml of sterile PBS twice through the trachea. Total and differential cell counts in the BALF were determined with the standard hemocytometer and HEMA3 staining (Biochemical Sciences Inc, Swedesboro, NJ) using 200 μl of BALF for cytospin slide preparation (Morales-Mantilla et al., 2020; Lu et al., 2015).
Cell isolation from murine lung tissue
Request a detailed protocolMouse lung tissue was cut into 2 mm pieces and digested with collagenase type D (2 mg/ml; Worthington) and deoxyribonuclease (DNase) I (0.04 mg/ml; Roche) for 1 hr in a 37°C incubator. Single-cell suspensions from lung digest, spleen, and thymus were prepared by mincing through 40-μm cell strainers then washing and resuspension in complete RPMI media. Mouse lung and spleen single-cell suspensions were additionally overlaid on Lympholyte M cell separation media (Cedarlane) as indicated in the manufacturer’s protocol to purify lymphocytes. For murine Mirlet7 expression studies, lung single-cell suspensions were labeled with anti-CD4+ or anti-CD8+ magnetic beads and separated by autoMACS (Miltenyi Biotec), or CD4+CD8+ DP cells purified from thymus single-cell suspensions by flow-cytometric sorting on FACS Aria (BD Biosciences).
In vitro polarization of CD8+ T cells
Request a detailed protocolCD8+ naive T cells were isolated from spleen using Mojosort Mouse CD8 Naïve T cell isolation Kit (Biolegend) and adjusted to a concentration of 1.0 × 106 cells/ml. Purified cells were activated with plate-bound anti-CD3 (1.5 µg/mL) and complete RPMI media containing anti-CD28 (1.5 µg/ml) and β-mercaptoethanol (50 nM) for Tc0 polarization, or further supplemented with Tc1 [IL-2 (10 ng/ml)] or Tc17 [TGFβ (2 ng/ml), IL-6 (20 ng/ml), anti-IFNγ (10 µg/ml), IL-23 (20 ng/ml), and IL-1β (5 ng/ml)] polarization conditions for 72 hr (Flores-Santibáñez et al., 2018).
ELISA
Request a detailed protocolSupernatant was collected from in vitro polarized murine CD8+ T cells and centrifuged to remove cellular debris (Lu et al., 2015). Cytokine levels of IL-17A and IFNγ were quantified from collected supernatant using Mouse IL-17A Uncoated ELISA and Mouse IFN gamma Uncoated ELISA (Invitrogen) Kits, respectively, per the manufacturer’s instructions with colorimetric analysis by the Varioskan LUX microplate reader (Thermo Fisher).
Flow cytometric analysis
Request a detailed protocolCells used for in vitro or in vivo cytokine analysis were stimulated with PMA (20 ng/ml; Sigma-Aldrich), Ionomycin (1 µg/ml; Sigma-Aldrich), and Brefeldin A (2 µg/ml; Sigma-Aldrich) for 4 hr prior to flow staining (Lu et al., 2015). For intracellular staining, cells were fixed and permeabilized using the Mouse FOXP3 Buffer Set (BD) per the manufacturer’s protocol. The fluorophore-conjugated antibodies used in this study were as follows: Live/Dead Fix Blue (Invitrogen), CD3 PerCPCy5.5 (Biolegend), TCRb PE/Cy7 (Biolegend), CD4 PB (Biolegend), CD4 AF700 (Biolegend), CD8 BV650 (Biolegend), CD25 BV421 (Biolegend), FOXP3 AF488 (Biolegend), ROR gamma T PE (Invitrogen), TCF1 AF647 (Cell Signaling Technologies), TCF1 PE (Biolegend), IFNγ AF647 (Biolegend), IL17A FITC (Biolegend), and IL17A PE (ebioscience). Samples were analyzed using BD LSR II flow cytometer (BD Biosciences) and FlowJo software (TreeStar).
RNA isolation and quantitative RT-PCR
Request a detailed protocolRNA was isolated using miRNeasy (QIAGEN) or RNeasy Mini Kit (QIAGEN) in conjunction with the RNase-Free DNase (QIAGEN) according to the manufacturer’s instructions. cDNA of miRNAs and mRNAs was synthesized using TaqMan Advanced miRNA cDNA Synthesis Kit (Thermo Fisher) and High-Capacity cDNA Reverse Transcription Kit Real-Time PCR system (Applied Biosystems). 18S and snoRNA-202 were used to normalize mRNA and miRNA expression, respectively (Lu et al., 2015). Quantitative RT-PCR data were acquired on 7500 Real-Time PCR System or StepOne Real-Time PCR System (Applied Biosystems) with the following TaqMan probes: hsa-let-7a-5p [478575_mir], hsa-let-7b-5p [478576_mir], hsa-let-7d [478439_mir], hsa-let-7f [478578_mir], pri-let7a1/f1/d [44411114, arfvmhy], pri-let7b/c2 [4441114, areptx2], Mmp9 [Mm00442991], and Mmp12 [Mm00500554].
Luciferase reporter assays
Request a detailed protocolGenomic fragment containing the murine Rorc 3′UTR was cloned into psiCHECK2 luciferase reporter plasmid (Promega). This construct was also used to generate the Mirlet7 ʻseedʼ deletion mutant derivative using the QuikChange Multi Site Mutagenesis Kit (catalog 200514-5, Stratagene). 3T3 mouse embryonic fibroblasts were transfected using Oligofectamine (Invitrogen) with 100 ng of psiCheck-2 plasmid containing wild-type or mutant 3′UTR, along with the miRNA control or Mirlet7b duplex (Dharmacon) at a final concentration of 6 nM (Gurha et al., 2012; Supplementary file 1). Reporter activity was detected with the Dual-Luciferase Reporter Assay System (Promega).
Statistical analysis
Request a detailed protocolStatistical analyses were performed using GraphPad Prism 10.0.1 software. Statistical comparison between groups was performed using the unpaired Student’s t-test, two-way analysis of variance with Tukey’s or Sidak’s correction, and Mann–Whitney test when indicated. A p-value less than 0.05 was considered statistically significant; ns indicates not significant. Statistical significance values were set as *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. Data are presented as means ± standard error of the mean. p-value and n can be found in the main and supplementary figure legends.
Data availability
Source data files for main figures are provided in the manuscript.
-
NCBI Gene Expression OmnibusID GSE57148. Comprehensive Analysis of Transcriptome Sequencing Data in the Lung Tissues of COPD Subjects.
References
-
Smoking and lung function of Lung Health Study participants after 11 yearsAmerican Journal of Respiratory and Critical Care Medicine 166:675–679.https://doi.org/10.1164/rccm.2112096
-
Inflammatory mechanisms in patients with chronic obstructive pulmonary diseaseThe Journal of Allergy and Clinical Immunology 138:16–27.https://doi.org/10.1016/j.jaci.2016.05.011
-
IL-17 in Chronic Inflammation: From Discovery to TargetingTrends in Molecular Medicine 22:230–241.https://doi.org/10.1016/j.molmed.2016.01.001
-
Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD)American Journal of Respiratory and Critical Care Medicine 192:1171–1178.https://doi.org/10.1164/rccm.201504-0736OC
-
Lin28b Regulates Fetal Regulatory T Cell Differentiation through Modulation of TGF-β SignalingJournal of Immunology 197:4344–4350.https://doi.org/10.4049/jimmunol.1601070
-
Antiviral CD8+ T-cell immune responses are impaired by cigarette smoke and in COPDThe European Respiratory Journal 62:2201374.https://doi.org/10.1183/13993003.01374-2022
-
The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patientsInternational Immunopharmacology 11:1780–1788.https://doi.org/10.1016/j.intimp.2011.06.010
-
Persistence of Th17/Tc17 Cell Expression upon Smoking Cessation in Mice with Cigarette Smoke-Induced EmphysemaClinical and Developmental Immunology 2013:1–11.https://doi.org/10.1155/2013/350727
-
An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary diseaseAmerican Journal of Respiratory and Critical Care Medicine 182:693–718.https://doi.org/10.1164/rccm.200811-1757ST
-
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitisEuropean Journal of Immunology 43:104–114.https://doi.org/10.1002/eji.201242702
-
Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challengeJournal of Immunology 182:3469–3481.https://doi.org/10.4049/jimmunol.0801814
-
The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthmaTherapeutic Advances in Respiratory Disease 10:158–174.https://doi.org/10.1177/1753465815618113
-
The neutrophil in chronic obstructive pulmonary disease. Too little, too late or too much, too soon?American Journal of Respiratory Cell and Molecular Biology 48:531–539.https://doi.org/10.1165/rcmb.2012-0492TR
-
The nature of small-airway obstruction in chronic obstructive pulmonary diseaseThe New England Journal of Medicine 350:2645–2653.https://doi.org/10.1056/NEJMoa032158
-
IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitisThe Journal of Clinical Investigation 123:247–260.https://doi.org/10.1172/JCI63681
-
Transcriptional regulation of Th17 cell differentiationSeminars in Immunology 19:409–417.https://doi.org/10.1016/j.smim.2007.10.011
-
Contribution of adaptive immunity to human COPD and experimental models of emphysemaPhysiological Reviews 103:1059–1093.https://doi.org/10.1152/physrev.00036.2021
-
Comprehensive Analysis of Transcriptome Sequencing Data in the Lung Tissues of COPD SubjectsInternational Journal of Genomics 2015:206937.https://doi.org/10.1155/2015/206937
-
Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 centuryInternational Journal of Environmental Research and Public Health 6:209–224.https://doi.org/10.3390/ijerph6010209
-
Antielastin autoimmunity in tobacco smoking-induced emphysemaNature Medicine 13:567–569.https://doi.org/10.1038/nm1583
-
Disruption of th17/treg balance in the sputum of patients with chronic obstructive pulmonary diseaseThe American Journal of the Medical Sciences 349:392–397.https://doi.org/10.1097/MAJ.0000000000000447
-
Cigarette smoke exposure in mice using a whole-body inhalation systemJournal of Visualized Experiments 01:61793.https://doi.org/10.3791/61793
-
Estrogen and progesterone decrease let-7f microRNA expression and increase IL-23/IL-23 receptor signaling and IL-17A production in patients with severe asthmaThe Journal of Allergy and Clinical Immunology 136:1025–1034.https://doi.org/10.1016/j.jaci.2015.05.046
-
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary diseaseAmerican Journal of Respiratory and Critical Care Medicine 163:1256–1276.https://doi.org/10.1164/ajrccm.163.5.2101039
-
The cellular composition of induced sputum in chronic obstructive pulmonary diseaseThe European Respiratory Journal 13:839–843.https://doi.org/10.1034/j.1399-3003.1999.13d24.x
-
Survival of Naïve T Cells Requires the Expression of Let-7 miRNAsFrontiers in Immunology 10:955.https://doi.org/10.3389/fimmu.2019.00955
-
Proinflammatory role for let-7 microRNAS in experimental asthmaThe Journal of Biological Chemistry 285:30139–30149.https://doi.org/10.1074/jbc.M110.145698
-
MicroRNA Expression in Induced Sputum of Smokers and Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine 183:898–906.https://doi.org/10.1164/rccm.201002-0304OC
-
Identification of mammalian microRNA host genes and transcription unitsGenome Research 14:1902–1910.https://doi.org/10.1101/gr.2722704
-
Chronic obstructive pulmonary disease (COPD)American Journal of Respiratory and Critical Care Medicine 157:S139–S147.https://doi.org/10.1164/ajrccm.157.4.nhlbi-12
-
Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysemaScience Translational Medicine 1:4ra10.https://doi.org/10.1126/scitranlsmed.3000154
-
Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysemaScience Translational Medicine 4:117ra9.https://doi.org/10.1126/scitranslmed.3003041
-
Agonistic induction of PPARγ reverses cigarette smoke-induced emphysemaThe Journal of Clinical Investigation 124:1371–1381.https://doi.org/10.1172/JCI70587
-
Interleukin 17 is a chief orchestrator of immunityNature Immunology 18:612–621.https://doi.org/10.1038/ni.3742
-
Role of viruses in exacerbations of chronic obstructive pulmonary diseaseProceedings of the American Thoracic Society 1:115–120.https://doi.org/10.1513/pats.2306030
-
Autoreactive T Cells in Human Smokers is Predictive of Clinical OutcomeFrontiers in Immunology 3:267.https://doi.org/10.3389/fimmu.2012.00267
-
MicroRNAs and other mechanisms regulate interleukin-17 cytokines and receptorsFrontiers in Bioscience E4:1478–1495.https://doi.org/10.2741/e474
-
Cigarette smoke-initiated autoimmunity facilitates sensitisation to elastin-induced COPD-like pathologies in miceThe European Respiratory Journal 56:2000404.https://doi.org/10.1183/13993003.00404-2020
Article and author information
Author details
Funding
National Heart, Lung, and Blood Institute (R01HL140398)
- Antony Rodriguez
National Institute of Environmental Health Sciences (T32 ES027801)
- Phillip A Erice
Gilson Longenbaugh Foundation
- Antony Rodriguez
The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.
Acknowledgements
We thank Jason Heaney and Denise Lanza at BCM Genetically Engineered Rodents Core funded in part by NIH P30 CA125123; Patricia Castro at Tissue Acquisition and Pathology Core funded in part by P30 CA125123; and Joel M Sederstrom at the BCM and Cell Sorting Core with funding from the CPRIT Core Facility Support Award (CPRIT-RP180672) and NIH (CA125123 and RR024574). This work was supported by grants from the NHLBI (R01HL140398 to AR), the Gilson Longenbaugh Foundation (to AR), and NIEHS (T32 ES027801 to PE).
Ethics
This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved Institutional Animal Care and Use Committee (IACUC) protocol (AN-7398) at Baylor College of Medicine.
The original design, eligibility and results of Human Subjects samples was published (Shan et al., 2009). Patients were recruited into the chest or surgical clinics at Michael E. DeBakey Houston Veterans Affairs Medical Center hospitals. All studies were approved by the Institutional Review Board at Baylor College of Medicine and informed consent was obtained from all patients.
Version history
- Sent for peer review:
- Preprint posted:
- Reviewed Preprint version 1:
- Reviewed Preprint version 2:
- Version of Record published:
Cite all versions
You can cite all versions using the DOI https://doi.org/10.7554/eLife.92879. This DOI represents all versions, and will always resolve to the latest one.
Copyright
© 2024, Erice et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 421
- views
-
- 38
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Genetics and Genomics
- Immunology and Inflammation
Systemic lupus erythematosus (SLE) is an autoimmune disease, the pathophysiology and genetic basis of which are incompletely understood. Using a forward genetic screen in multiplex families with SLE, we identified an association between SLE and compound heterozygous deleterious variants in the non-receptor tyrosine kinases (NRTKs) ACK1 and BRK. Experimental blockade of ACK1 or BRK increased circulating autoantibodies in vivo in mice and exacerbated glomerular IgG deposits in an SLE mouse model. Mechanistically, NRTKs regulate activation, migration, and proliferation of immune cells. We found that the patients’ ACK1 and BRK variants impair efferocytosis, the MERTK-mediated anti-inflammatory response to apoptotic cells, in human induced pluripotent stem cell (hiPSC)-derived macrophages, which may contribute to SLE pathogenesis. Overall, our data suggest that ACK1 and BRK deficiencies are associated with human SLE and impair efferocytosis in macrophages.
-
- Immunology and Inflammation
The adaptive T cell response is accompanied by continuous rewiring of the T cell’s electric and metabolic state. Ion channels and nutrient transporters integrate bioelectric and biochemical signals from the environment, setting cellular electric and metabolic states. Divergent electric and metabolic states contribute to T cell immunity or tolerance. Here, we report in mice that neuritin (Nrn1) contributes to tolerance development by modulating regulatory and effector T cell function. Nrn1 expression in regulatory T cells promotes its expansion and suppression function, while expression in the T effector cell dampens its inflammatory response. Nrn1 deficiency in mice causes dysregulation of ion channel and nutrient transporter expression in Treg and effector T cells, resulting in divergent metabolic outcomes and impacting autoimmune disease progression and recovery. These findings identify a novel immune function of the neurotrophic factor Nrn1 in regulating the T cell metabolic state in a cell context-dependent manner and modulating the outcome of an immune response.